NAVJOT KAUR: Open Payments
NPI 1003691049 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,269 in 107 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,269
Food & beverage: $2,269
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 43 | $800 |
| Ardelyx, Inc. | 24 | $431 |
| Gilead Sciences, Inc. | 9 | $303 |
| ABBVIE INC. | 8 | $264 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $248 |
| Ipsen Biopharmaceuticals, Inc | 3 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Intercept Pharmaceuticals, Inc. | 2 | $38 |
| PFIZER INC. | 2 | $35 |
| Madrigal Pharmaceuticals | 1 | $25 |
Products named: VOWST, IBSRELA, XIFAXAN, Epclusa, CREON, ZENPEP, IQIRVO, RINVOQ.
Industry payments across CA — which companies pay providers there.
